Literature DB >> 28730568

Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients.

Fan Wu1, Yuanyuan Jing1, Xiaojun Tang2, Dai Li1, Lilin Gong1, Hongyan Zhao1, Li He1, Qifu Li1, Rong Li3.   

Abstract

AIMS: Recently, the association between anemia and diabetic microvascular complications has been studied. Diabetic peripheral neuropathy (DPN) is also a common complication of type 2 diabetes mellitus (T2DM), while the relationship between anemia and DPN is rarely investigated. The aim of this study is to evaluate the association between anemia and DPN in T2DM.
METHODS: In this cross-sectional study, 1134 T2DM inpatients were enrolled. The diagnosis of DPN was based on neuropathy system score (NSS) and neuropathy disability score (NDS). Logistic regression was conducted to analyze the association between anemia and DPN.
RESULTS: The proportions of anemia in DPN and non-DPN group were 25.4 and 15.2%, respectively. Compared with non-anemia group, the proportions of moderate/severe NSS (42.7 vs. 24.5%, P < 0.001) and moderate/severe NDS (51.5 vs. 38.0%, P < 0.001) were higher while the nerve conduction velocity (NCV) was lower in anemia group. Univariate logistic regression analysis showed patients with anemia possessed an increased risk of DPN [OR = 1.906, 95%CI: 1.416, 2.567, P < 0.001]. Multivariate logistic regression analysis suggested anemia was an independent risk factor of DPN in model 1 and model 2 [model 1: OR = 1.472, 95%CI: 1.047, 2.070, P = 0.026; model 2: OR = 1.448, 95%CI: 1.013, 2.071, P = 0.043].
CONCLUSIONS: Anemia is an independent risk factor of DPN in T2DM patients.

Entities:  

Keywords:  Anemia; Diabetic peripheral neuropathy; Microvascular complication; Type 2 diabetes mellitus

Mesh:

Year:  2017        PMID: 28730568     DOI: 10.1007/s00592-017-1025-7

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  6 in total

1.  HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Cardiovasc Diabetol       Date:  2018-03-29       Impact factor: 9.951

2.  Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies.

Authors:  Syed Shah Zaman Haider Naqvi; Saber Imani; Hossein Hosseinifard; Qing-Lian Wen; M Naveed Shahzad; Iqra Ijaz; Youcai Deng; Man Guo; Yong Xu
Journal:  BMC Endocr Disord       Date:  2019-11-25       Impact factor: 2.763

3.  Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.

Authors:  David Mizrahi; Susanna B Park; Tiffany Li; Hannah C Timmins; Terry Trinh; Kimberley Au; Eva Battaglini; David Wyld; Robert D Henderson; Peter Grimison; Helen Ke; Peter Geelan-Small; Julie Marker; Brian Wall; David Goldstein
Journal:  JAMA Netw Open       Date:  2021-02-01

4.  Association Between Early Markers of Renal Injury and Type 2 Diabetic Peripheral Neuropathy.

Authors:  Zhi Yang; Xiaoyang Lou; Jie Zhang; Ronghui Nie; Jiang Liu; Ping Tu; Peng Duan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-10-30       Impact factor: 3.168

5.  Sports Injury Identification Method Based on Machine Learning Model.

Authors:  Zexu Liu; Jun Zhang; Di Wu
Journal:  Comput Intell Neurosci       Date:  2022-08-08

6.  Prevalence of and Risk Factors for Peripheral Neuropathy in Chinese Patients With Diabetes: A Multicenter Cross-Sectional Study.

Authors:  Qi Pan; Quanmin Li; Wei Deng; Dong Zhao; Lin Qi; Wei Huang; Li Ma; Hongmei Li; Yufeng Li; Xiaofeng Lyu; Aihong Wang; Hebin Yao; Xiaoyan Xing; Lixin Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-05       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.